Peripheral Arthritis in Patients Classified as Having Nonradiographic Axial Spondyloarthritis in Trials of Anti–Tumor Necrosis Factor Agents: Comment on the Article by Dougados et al

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|4|1138-1139

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.4, 2015-04, pp. : 1138-1139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2369-2375

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medication Persistence of Disease‐Modifying Antirheumatic Drugs and Anti–Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil

By  

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1489-1496

John Wiley & Sons Inc

Access to resources Recommend Favorite

The risk of tuberculosis in patients with psoriasis treated with anti‐tumor necrosis factor agents

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : 594-599

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment With Anti–Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I–Positive Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 5, 2014-05 ,pp. : 788-792

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 6, 2015-05 ,pp. : 842-847

John Wiley & Sons Inc

Access to resources Recommend Favorite